CMX has the proficiency, skill and expertise to monitor your clinical trial. As an established CRO, we have managed and conducted over 60 Phase I to Phase IV trials.
Contact us today to take advantage of our superior monitoring services.
CMX has also monitored over 75 Bioavailability/Bioequivalent (BA/BE) studies for multiple pharmaceutical companies across the globe.
Monitoring is conducted effectively and efficiently by trained and certified Clinical Research Associates (CRAs). Our services include Site Qualification Visits (SQVs), Site Initiation Visits (SIVs), Interim Monitoring Visits (IMVs), and Close-Out Visits (COVs) and are coordinated according to the sponsor’s requirements or monitoring plan.
All studies will be monitored for compliance to ICH GCP. A regulatory overview includes reviewing the Site Master File (SMF) and the essential documents to ensure data integrity.